{"meta":{"query_hash":"5251c2c95b64","filters":{"venue":"European Journal of Drug Metabolism and Pharmacokinetics"},"cohort_total":37,"direct_labels_cover":0,"predictions_cover":37,"exported":37,"export_cap":100000,"truncated":false,"label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12"},"permalink":"https://metacan.xera.ac/q/5251c2c95b64","api":"https://metacan.xera.ac/api/v1/cohort?venue=European+Journal+of+Drug+Metabolism+and+Pharmacokinetics"},"results":[{"id":"W1926309879","doi":"10.1007/bf03226382","title":"Assessment of the involvement of CYP3A in the vitro metabolism of a new modulator of MDR in cancer chemotherapy, OC144-193, by human liver microsomes","year":2001,"lang":"en","type":"article","venue":"European Journal of Drug Metabolism and Pharmacokinetics","topic":"Drug Transport and Resistance Mechanisms","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"CYP3A4; Microsome; CYP3A; Pharmacology; P-glycoprotein; CYP2B6; Ketoconazole; Doxorubicin; Cytochrome P450; In vivo; Drug metabolism; Metabolite; Biology; Chemistry; In vitro; Biochemistry; Multiple drug resistance; Enzyme; Drug; Chemotherapy","score_opus":0.019632549348454664,"score_gpt":0.296693781293974,"score_spread":0.27706123194551935,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1926309879","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9940036,0.0022399453,0.0020246163,0.000109768735,0.000019785894,0.000059525846,0.00023753071,0.000045104884,0.0012600197],"genre_scores_gemma":[0.99637944,0.00079594576,0.0012560561,0.00002245162,0.000014026343,0.000035755544,0.0005216038,0.00002408852,0.0009506647],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9996749,0.00018685164,0.000020121692,0.000027845368,0.000045918223,0.000044420914],"domain_scores_gemma":[0.9996892,0.00013619078,0.0000498162,0.00005227095,0.000041792875,0.000030717576],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00061989157,0.00041094254,0.00043381425,0.00030616162,0.0003866083,0.00038806,0.00022083153,0.00044349677,0.001602439],"category_scores_gemma":[0.0010680717,0.00030760813,0.00041850077,0.0003299592,0.00025359893,0.0003158097,0.0001465183,0.0005883424,0.0004067059],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0050321235,0.00022605223,0.0040181256,0.0001367099,0.000092082184,0.0002966327,0.000178096,0.0007946824,0.9739667,0.00037478007,0.00021503918,0.01466898],"study_design_scores_gemma":[0.00020491978,0.003922753,0.01035917,0.000013308283,0.00016104184,0.0007122059,0.000059431342,0.0026985705,0.9797752,0.0000983682,0.0019769673,0.000018069979],"about_ca_topic_score_codex":0.0029891704,"about_ca_topic_score_gemma":0.0030321085,"teacher_disagreement_score":0.0029891704,"about_ca_system_score_codex":0.0003647663,"about_ca_system_score_gemma":0.00060067466,"threshold_uncertainty_score":0.0059435368},"labels":[],"label_agreement":null},{"id":"W1969417922","doi":"10.1007/s13318-014-0205-x","title":"A metoprolol–terbinafine combination induced bradycardia","year":2014,"lang":"en","type":"article","venue":"European Journal of Drug Metabolism and Pharmacokinetics","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Hôpital du Sacré-Cœur de Montréal","funders":"","keywords":"Metoprolol; Bradycardia; Medicine; Sinus bradycardia; Anesthesia; Terbinafine; Bisoprolol; Heart rate; Coronary artery disease; Adverse effect; Cardiology; Internal medicine; Pharmacology; Heart failure; Blood pressure; Dermatology","score_opus":0.0174463820794326,"score_gpt":0.2840406483624154,"score_spread":0.2665942662829828,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1969417922","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99168783,0.0013709855,0.0021866392,0.00086581416,0.00035738925,0.00018507915,0.00023117801,0.00012097075,0.0029941648],"genre_scores_gemma":[0.9982439,0.00029702432,0.00027174337,0.000358407,0.0000676775,0.000026071008,0.000075198484,0.000008138781,0.0006518899],"study_design_codex":"bench_or_experimental","study_design_gemma":"case_report","domain_scores_codex":[0.999806,0.00005519325,0.000022993469,0.000038857455,0.000040171257,0.000036796762],"domain_scores_gemma":[0.9996704,0.00012964013,0.00006802073,0.000035916913,0.000015970654,0.000080024045],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001499865,0.00039688984,0.0005769919,0.0001785893,0.00020301096,0.00019886014,0.00026001086,0.0007382755,0.0014987749],"category_scores_gemma":[0.000712952,0.00015732207,0.00044758414,0.0001773598,0.0001825418,0.0001584418,0.00015288549,0.0019337228,0.0002777353],"study_design_candidate":"case_report","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.061776806,0.0054237493,0.01867725,0.0006123587,0.0006991582,0.23936702,0.00042580935,0.0015281822,0.5030602,0.0010294662,0.0037588116,0.16364111],"study_design_scores_gemma":[0.011978524,0.14702676,0.22147374,0.00009274375,0.0012021739,0.3705078,0.00035824487,0.016338011,0.20373239,0.0009585283,0.026177535,0.00015356093],"about_ca_topic_score_codex":0.00063726417,"about_ca_topic_score_gemma":0.0008357518,"teacher_disagreement_score":0.0014987749,"about_ca_system_score_codex":0.00035048937,"about_ca_system_score_gemma":0.00023873943,"threshold_uncertainty_score":0.0050139427},"labels":[],"label_agreement":null},{"id":"W1987395036","doi":"10.1007/bf03190076","title":"Metabolism of clozapine by rat brain: the role of flavin-containing monooxygenase (FMO) and cytochrome P450 enzymes","year":2000,"lang":"en","type":"article","venue":"European Journal of Drug Metabolism and Pharmacokinetics","topic":"Schizophrenia research and treatment","field":"Medicine","cited_by":30,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Clozapine; Flavin-containing monooxygenase; Chemistry; Pharmacology; Monooxygenase; Cytochrome P450; Biochemistry; Metabolism; Biology; Medicine; Schizophrenia (object-oriented programming)","score_opus":0.00962137449934509,"score_gpt":0.26108358265706333,"score_spread":0.25146220815771825,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1987395036","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.987811,0.006466704,0.0026716194,0.00027418474,0.000034555454,0.000034511126,0.00063156884,0.00009627947,0.0019795888],"genre_scores_gemma":[0.9873963,0.005624584,0.0025978312,0.00008166611,0.000032676086,0.000035398458,0.0011980988,0.000029667994,0.00300379],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99992704,0.0000160599,0.0000032101425,0.0000097990915,0.000010194488,0.000033581407],"domain_scores_gemma":[0.9998087,0.00004679086,0.000046135166,0.000029503986,0.000026993634,0.000041889256],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000117853204,0.0007598183,0.00043260283,0.00064644293,0.00045048323,0.0004992811,0.00029664725,0.00041803403,0.0017869463],"category_scores_gemma":[0.0003584527,0.0002971936,0.00039335317,0.00040458963,0.00041282744,0.0005213358,0.00019317174,0.0007438021,0.0004634868],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.018464597,0.0003292389,0.0048575685,0.0003865275,0.00012364864,0.0011550206,0.00027005957,0.0008040471,0.9393517,0.0011291461,0.0005822893,0.032546107],"study_design_scores_gemma":[0.00021757431,0.0027732817,0.03384276,0.000046090998,0.00034671093,0.0012303804,0.0003543891,0.0031827972,0.9530426,0.00062639295,0.004293737,0.00004319509],"about_ca_topic_score_codex":0.025255986,"about_ca_topic_score_gemma":0.03903653,"teacher_disagreement_score":0.025255986,"about_ca_system_score_codex":0.00090700114,"about_ca_system_score_gemma":0.0009718594,"threshold_uncertainty_score":0.050217927},"labels":[],"label_agreement":null},{"id":"W1996171153","doi":"10.1007/bf03190426","title":"Drug interaction studies between paclitaxel (Taxol) and OC144-093 — A new modulator of MDR in cancer chemotherapy","year":2002,"lang":"en","type":"article","venue":"European Journal of Drug Metabolism and Pharmacokinetics","topic":"Drug Transport and Resistance Mechanisms","field":"Medicine","cited_by":33,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Paclitaxel; Chemotherapy; Drug; Pharmacology; Cancer; Medicine; Anticancer drug; Cancer chemotherapy; Internal medicine","score_opus":0.04791170190154007,"score_gpt":0.31955224672439864,"score_spread":0.27164054482285854,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1996171153","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99744993,0.0013503431,0.00029266087,0.000051539468,0.000019418068,0.0000593695,0.00010180689,0.000013863962,0.00066113233],"genre_scores_gemma":[0.9970393,0.0010710214,0.00067882956,0.000031761392,0.000037933267,0.000026236372,0.000226106,0.000014425967,0.000874414],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9994733,0.00031398435,0.000027547203,0.000036996204,0.00007775268,0.00007049764],"domain_scores_gemma":[0.999468,0.00030816853,0.000085923035,0.000025609064,0.00005236834,0.00005982415],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00048582564,0.00026432957,0.0007455752,0.00046664567,0.00039738865,0.00029706894,0.00030320717,0.0002797073,0.0018955574],"category_scores_gemma":[0.0011803107,0.00022719192,0.0005000786,0.00047191783,0.00023303385,0.00031011342,0.00017251726,0.00053174706,0.00031730635],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.047262195,0.004152924,0.015973695,0.00058798445,0.00076333305,0.0014071149,0.00055311515,0.004565846,0.8733445,0.0007454435,0.0016011785,0.049042698],"study_design_scores_gemma":[0.0036933073,0.07927837,0.078801416,0.000035391728,0.0015944957,0.0048286496,0.00036193084,0.027322074,0.78911257,0.0002464757,0.01462305,0.00010238075],"about_ca_topic_score_codex":0.0045057912,"about_ca_topic_score_gemma":0.0035981114,"teacher_disagreement_score":0.0045057912,"about_ca_system_score_codex":0.0004992171,"about_ca_system_score_gemma":0.00041633612,"threshold_uncertainty_score":0.008959115},"labels":[],"label_agreement":null},{"id":"W2015768303","doi":"10.1007/bf03190051","title":"Dissolution and in vivo evidence of differences in reference products: impact on development of generic drugs","year":2000,"lang":"en","type":"article","venue":"European Journal of Drug Metabolism and Pharmacokinetics","topic":"Pharmaceutical studies and practices","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Apotex (Canada); University of Toronto","funders":"World Health Organization","keywords":"In vivo; Human physiology; Pharmacy; Drug development; Pharmacology; Pharmaceutical technology; Chemistry; Medicine; Drug; Internal medicine; Biology; Biotechnology; Family medicine; Chromatography","score_opus":0.07679717120738065,"score_gpt":0.3537791295833442,"score_spread":0.2769819583759635,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2015768303","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96717304,0.01561293,0.009183862,0.0011759284,0.00018516002,0.00020633375,0.0010743102,0.0000646178,0.005323854],"genre_scores_gemma":[0.99190813,0.0025112352,0.0032493027,0.00032654812,0.00008144612,0.000021065593,0.0009311011,0.000051177314,0.00091992744],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9844223,0.01073436,0.00077640725,0.000959098,0.0028347059,0.00027302245],"domain_scores_gemma":[0.98408335,0.0071880333,0.00336759,0.00221293,0.0026335947,0.00051443675],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0077353697,0.00055784156,0.00076678547,0.0008500188,0.00040036143,0.001346402,0.0008902539,0.0017431738,0.0023287493],"category_scores_gemma":[0.024668895,0.00034214256,0.0007562109,0.00094500254,0.0011586805,0.0009279095,0.000577262,0.0015757027,0.00061326433],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.066414855,0.0029851233,0.05956162,0.0012514215,0.001117154,0.0008875601,0.0012285542,0.0027762253,0.7209757,0.0024721853,0.0016071361,0.13872242],"study_design_scores_gemma":[0.0015039613,0.06486022,0.11783341,0.00020351978,0.0021583855,0.0038291186,0.0006600831,0.004333968,0.7861879,0.001252024,0.017054288,0.00012316667],"about_ca_topic_score_codex":0.0014105842,"about_ca_topic_score_gemma":0.0009965175,"teacher_disagreement_score":0.0077353697,"about_ca_system_score_codex":0.0007670475,"about_ca_system_score_gemma":0.0007142785,"threshold_uncertainty_score":0.040909052},"labels":[],"label_agreement":null},{"id":"W2021808739","doi":"10.1007/bf03190602","title":"Metabolic and pharmacokinetic evaluation of a Novel 3-hydroxypyridinone iron chelator, CP502, in the rat","year":2004,"lang":"en","type":"article","venue":"European Journal of Drug Metabolism and Pharmacokinetics","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Apotex (Canada); University of Toronto","funders":"","keywords":"Pharmacokinetics; Bioavailability; Pharmacology; Chemistry; Urine; Oral administration; Dosing; Clinical chemistry; Potency; Chelation; Excretion; Medicine; Biochemistry; In vitro","score_opus":0.022969647272310715,"score_gpt":0.28807151443531054,"score_spread":0.2651018671629998,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2021808739","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9951585,0.0010442123,0.002155752,0.00014770486,0.00003368711,0.00006352404,0.00052262493,0.000117538424,0.00075646705],"genre_scores_gemma":[0.99169356,0.0016215511,0.0028367587,0.00009889148,0.000042655778,0.000095556854,0.0009313077,0.000069214584,0.0026103433],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.999828,0.00004677035,0.000009751232,0.00003853077,0.00002572135,0.000051120827],"domain_scores_gemma":[0.99955183,0.000051974283,0.00012671888,0.00007977386,0.00006240222,0.0001272981],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004171523,0.0007347923,0.00068269187,0.0005056074,0.00039149093,0.0004776066,0.0004942274,0.00076071336,0.0010040953],"category_scores_gemma":[0.0004891684,0.0005344327,0.0005385333,0.00038028634,0.0005950584,0.00084068184,0.00013583634,0.0011885449,0.00035292242],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.034126427,0.0022084545,0.0010852428,0.00016848088,0.00010754452,0.00023755828,0.00013486635,0.0012034512,0.942777,0.00035334952,0.0005287727,0.017068902],"study_design_scores_gemma":[0.0014515345,0.029714996,0.0066300686,0.000019118494,0.00036790248,0.0005288846,0.00012231688,0.004251874,0.95333564,0.00012794223,0.0033901269,0.000059734495],"about_ca_topic_score_codex":0.004586678,"about_ca_topic_score_gemma":0.00471592,"teacher_disagreement_score":0.004586678,"about_ca_system_score_codex":0.00071276346,"about_ca_system_score_gemma":0.0011152485,"threshold_uncertainty_score":0.009119928},"labels":[],"label_agreement":null},{"id":"W2061416714","doi":"10.1007/bf03190370","title":"Induction and inactivation of a cytochrome P450 confering herbicide resistance in wheat seedlings","year":2001,"lang":"en","type":"article","venue":"European Journal of Drug Metabolism and Pharmacokinetics","topic":"Weed Control and Herbicide Applications","field":"Agricultural and Biological Sciences","cited_by":24,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Guelph","funders":"","keywords":"Bentazon; Cytochrome P450; Lauric acid; Hydroxylation; Chemistry; Enzyme; In vivo; Metabolism; Biochemistry; Monooxygenase; Biology; Fatty acid; Botany","score_opus":0.01697965664784809,"score_gpt":0.23388240194586643,"score_spread":0.21690274529801834,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2061416714","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9959318,0.00048626162,0.0021985348,0.00012573761,0.00003745919,0.00003451834,0.00037127527,0.00015092701,0.00066341355],"genre_scores_gemma":[0.9961278,0.00018712372,0.0007919665,0.000053710923,0.000007665562,0.000025908188,0.00052332535,0.00003806761,0.0022444474],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99981993,0.000026500418,0.00001598685,0.000051946052,0.00003252772,0.000053189735],"domain_scores_gemma":[0.999713,0.00007812294,0.00006352962,0.000046949437,0.000031182743,0.00006712049],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017092527,0.00048641764,0.00035779583,0.00025714835,0.00021518339,0.0003449497,0.0002555655,0.00041843057,0.0013655605],"category_scores_gemma":[0.00023284351,0.0002671273,0.00038506032,0.00019096296,0.00024697703,0.0002633096,0.00022644429,0.0010221505,0.0003270566],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007950084,0.000016311758,0.00010215784,0.0000086127775,0.000002515417,0.000026914993,0.0000113809065,0.000017751865,0.9993519,0.000039827886,0.000019830908,0.00032323462],"study_design_scores_gemma":[0.00003191735,0.00044165942,0.0092463875,0.000003124315,0.000016991104,0.0001348905,0.00004625643,0.00072606216,0.98849946,0.000046343503,0.00079889235,0.000007965978],"about_ca_topic_score_codex":0.003121523,"about_ca_topic_score_gemma":0.0032433064,"teacher_disagreement_score":0.003121523,"about_ca_system_score_codex":0.00072501716,"about_ca_system_score_gemma":0.0003267225,"threshold_uncertainty_score":0.0062066913},"labels":[],"label_agreement":null},{"id":"W2072862596","doi":"10.1007/s13318-011-0072-7","title":"Metabolism studies of a small-molecule tumor necrosis factor-alpha (TNF-α) inhibitor, UTL-5b (GBL-5b)","year":2011,"lang":"en","type":"article","venue":"European Journal of Drug Metabolism and Pharmacokinetics","topic":"Inflammatory mediators and NSAID effects","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Surgical Specialties (Canada)","funders":"National Institute of Arthritis and Musculoskeletal and Skin Diseases; National Institutes of Health","keywords":"Leflunomide; Chemistry; Microsome; In vitro; Tumor necrosis factor alpha; Metabolism; Pharmacology; Metabolite; Biochemistry; Medicine; Internal medicine","score_opus":0.04177131014717696,"score_gpt":0.28112694570512564,"score_spread":0.2393556355579487,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2072862596","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9920632,0.004904331,0.0017860217,0.00009243931,0.0000297626,0.00004858539,0.00037736556,0.000027547912,0.0006706296],"genre_scores_gemma":[0.9957533,0.0012602712,0.0011140107,0.00005013622,0.000015263933,0.000027252556,0.0005596653,0.000020466736,0.0011996125],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998246,0.00007540617,0.000011437997,0.00002920196,0.000028271543,0.000031187086],"domain_scores_gemma":[0.9998265,0.000036440124,0.000046698253,0.000020228785,0.000024110064,0.000046075747],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000340437,0.0003266045,0.0004135538,0.0002663552,0.00030932116,0.00038124612,0.00022782228,0.00032596465,0.0018120981],"category_scores_gemma":[0.00052393,0.00027768261,0.0004492895,0.00027035206,0.00026716499,0.00037923016,0.00014379855,0.0006343993,0.0004915419],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.018970124,0.0007841724,0.003107134,0.00016978287,0.00015392998,0.0002866246,0.00014889044,0.00084555434,0.9600193,0.0002422363,0.00029936022,0.014972887],"study_design_scores_gemma":[0.00068195746,0.014853509,0.015687825,0.000015617039,0.0002855451,0.0017987262,0.00013760694,0.0038499797,0.9574868,0.0001006485,0.005071736,0.000029892935],"about_ca_topic_score_codex":0.003462428,"about_ca_topic_score_gemma":0.0023127692,"teacher_disagreement_score":0.003462428,"about_ca_system_score_codex":0.00059951615,"about_ca_system_score_gemma":0.00045221756,"threshold_uncertainty_score":0.006884575},"labels":[],"label_agreement":null},{"id":"W2081266165","doi":"10.1007/bf03190054","title":"Differences in reference products: dissolution and in vivo evidence","year":2000,"lang":"en","type":"article","venue":"European Journal of Drug Metabolism and Pharmacokinetics","topic":"Statistical Methods in Clinical Trials","field":"Mathematics","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Pharmacists Association","funders":"","keywords":"Human physiology; In vivo; Dissolution; Clinical chemistry; Chemistry; Medicine; Pharmacology; Internal medicine; Biology; Biotechnology","score_opus":0.33785891534596624,"score_gpt":0.46446672292087726,"score_spread":0.12660780757491102,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2081266165","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7929917,0.1373833,0.054631885,0.002310295,0.0005267504,0.0005050842,0.0015055577,0.0001513567,0.009994099],"genre_scores_gemma":[0.9827786,0.008288671,0.006632793,0.00052320585,0.00019949043,0.0000469445,0.0006872064,0.000048166134,0.0007948447],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9773113,0.015489033,0.0016883662,0.0018808232,0.0033275478,0.00030288871],"domain_scores_gemma":[0.8907333,0.076261,0.017049456,0.010664015,0.0042222496,0.001069901],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.018367803,0.00066539977,0.0015735879,0.0009205872,0.00029306702,0.0016233712,0.0014949497,0.001739756,0.0029835338],"category_scores_gemma":[0.10827815,0.0004076174,0.0014830782,0.0011298158,0.0019025546,0.0020425217,0.000833185,0.0018931122,0.0005853695],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.28583756,0.0026301057,0.05596169,0.008360587,0.0067374757,0.0010953146,0.0020396656,0.005614526,0.04074338,0.029144388,0.0052276817,0.5566076],"study_design_scores_gemma":[0.023892956,0.20353198,0.2978678,0.0026795024,0.01945374,0.017206168,0.0020352567,0.036061246,0.23982704,0.083583005,0.073417395,0.00044388196],"about_ca_topic_score_codex":0.0006813403,"about_ca_topic_score_gemma":0.00025889376,"teacher_disagreement_score":0.018367803,"about_ca_system_score_codex":0.0006949562,"about_ca_system_score_gemma":0.00051982317,"threshold_uncertainty_score":0.09713936},"labels":[],"label_agreement":null},{"id":"W2084480461","doi":"10.1007/bf03190061","title":"Realities and implementation — report of the International Workshop on IBE, Montreal, Canada, August 1999","year":2000,"lang":"en","type":"article","venue":"European Journal of Drug Metabolism and Pharmacokinetics","topic":"Mathematics Education and Programs","field":"Mathematics","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Saskatchewan","funders":"","keywords":"Human physiology; Library science; Political science; Medicine; Internal medicine; Computer science","score_opus":0.028822042495909753,"score_gpt":0.3203651844755462,"score_spread":0.29154314197963643,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2084480461","genre_codex":"commentary","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.08025739,0.014724544,0.019671338,0.5625834,0.003135567,0.0026419375,0.004395621,0.0011044004,0.31148577],"genre_scores_gemma":[0.59636605,0.011716915,0.038477484,0.031299908,0.00043256386,0.0019057165,0.0056008655,0.0006987604,0.3135017],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.98184884,0.005538731,0.0005081956,0.0008945232,0.004933506,0.0062762196],"domain_scores_gemma":[0.974182,0.004078185,0.00078383484,0.0014016645,0.011518396,0.008035879],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.037517443,0.0006807366,0.0004915004,0.0011134455,0.006039502,0.012096819,0.0057605742,0.0038186563,0.025605753],"category_scores_gemma":[0.035204202,0.0010433313,0.00067882315,0.002287675,0.0050820885,0.005017202,0.0078124246,0.0057573197,0.0017407526],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005214108,0.001294001,0.018719966,0.0005929622,0.000074423464,0.0005575849,0.016246224,0.003894906,0.0021380736,0.06855421,0.5552203,0.3321858],"study_design_scores_gemma":[0.0001868351,0.00027734155,0.04499014,0.00097390165,0.000046642668,0.0001358548,0.031644113,0.0017021493,0.0021807207,0.0056722974,0.9120687,0.00012121921],"about_ca_topic_score_codex":0.8922657,"about_ca_topic_score_gemma":0.8924898,"teacher_disagreement_score":0.10773432,"about_ca_system_score_codex":0.061302997,"about_ca_system_score_gemma":0.20709012,"threshold_uncertainty_score":0},"labels":[],"label_agreement":null},{"id":"W2084505805","doi":"10.1007/s13318-014-0243-4","title":"Placental profiling of UGT1A enzyme expression and activity and interactions with preeclampsia at term","year":2014,"lang":"en","type":"article","venue":"European Journal of Drug Metabolism and Pharmacokinetics","topic":"Pregnancy and preeclampsia studies","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; University of British Columbia Hospital","funders":"National Institute on Minority Health and Health Disparities; National Center for Research Resources; National Institute of General Medical Sciences; National Institutes of Health","keywords":"Placenta; Biology; Fetus; Microsome; Enzyme; Glucuronosyltransferase; Preeclampsia; Messenger RNA; Andrology; Endocrinology; Pregnancy; Biochemistry; Internal medicine; Gene; Medicine; Genetics","score_opus":0.015217876883874286,"score_gpt":0.26610746491165327,"score_spread":0.250889588027779,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2084505805","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99367106,0.002752663,0.00056344224,0.00012652116,0.0000131080205,0.000012633998,0.000573382,0.00001952985,0.002267622],"genre_scores_gemma":[0.99739057,0.0010485358,0.0002335127,0.000041405685,0.000012055511,0.000012148303,0.000239996,0.000008398031,0.001013429],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.999688,0.00010024335,0.000017633865,0.000070609756,0.00007658376,0.000046882582],"domain_scores_gemma":[0.9993362,0.00024547408,0.00020668881,0.000056758876,0.00006825501,0.00008654869],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003753951,0.00020017257,0.00035690208,0.00080071704,0.00017876938,0.0006884791,0.0002079269,0.00030073244,0.00149759],"category_scores_gemma":[0.0019608897,0.00017999556,0.0002849477,0.0011465936,0.00029263063,0.00022606678,0.00027100625,0.0006173577,0.00020701556],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0055993935,0.00023957697,0.89629835,0.0001792546,0.00031002972,0.0026284382,0.0008737992,0.000405687,0.05599638,0.00052666117,0.000377718,0.036564678],"study_design_scores_gemma":[0.000012374443,0.00047573046,0.9872814,0.000018043762,0.0001535801,0.0016918596,0.00021517652,0.00033358767,0.0084312735,0.00017832806,0.0011988777,0.000009867319],"about_ca_topic_score_codex":0.0032464727,"about_ca_topic_score_gemma":0.0016317896,"teacher_disagreement_score":0.0032464727,"about_ca_system_score_codex":0.00045244527,"about_ca_system_score_gemma":0.0002926278,"threshold_uncertainty_score":0.006455183},"labels":[],"label_agreement":null},{"id":"W2129688365","doi":"10.1007/s13318-010-0005-x","title":"Survey: calculation of the characteristics of oral diffusion-controlled release dosage forms related to the drug","year":2010,"lang":"en","type":"article","venue":"European Journal of Drug Metabolism and Pharmacokinetics","topic":"Drug Solubulity and Delivery Systems","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Concordia University","funders":"","keywords":"Dosage form; Drug; Pharmacokinetics; Pharmacology; Diffusion; In vivo; Chemistry; Bioavailability; Biomedical engineering; Chromatography; Medicine; Thermodynamics; Physics; Biotechnology","score_opus":0.029386055024585037,"score_gpt":0.32721896644109405,"score_spread":0.297832911416509,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2129688365","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.5152886,0.19831762,0.259393,0.00082195405,0.00031835574,0.0005125033,0.008890448,0.002398269,0.014059127],"genre_scores_gemma":[0.8088178,0.07341074,0.10428166,0.00020372242,0.00021768275,0.00022775673,0.0068229227,0.00051650545,0.0055011795],"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9989635,0.00019484878,0.00012418837,0.00015281711,0.0005384392,0.000026256663],"domain_scores_gemma":[0.9971175,0.0013930887,0.00044735157,0.00019019985,0.00081233424,0.00003948724],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014132862,0.0005385605,0.00081748597,0.0020904914,0.00013465184,0.0006874242,0.00062187127,0.0004016667,0.0020304595],"category_scores_gemma":[0.004663624,0.00023503586,0.00094094966,0.0020553812,0.00018018892,0.0006341608,0.00025590858,0.00028603317,0.0012754573],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00093934697,0.0001910455,0.025219368,0.0061279,0.00022512292,0.00015829378,0.000069795984,0.011438187,0.07293267,0.0014671264,0.0042649386,0.8769663],"study_design_scores_gemma":[0.00016013271,0.003867359,0.15043119,0.00065420463,0.0010839483,0.0055314265,0.0002303078,0.109505005,0.57647234,0.0020918231,0.14972012,0.00025217287],"about_ca_topic_score_codex":0.00081754086,"about_ca_topic_score_gemma":0.00058418454,"teacher_disagreement_score":0.0020904914,"about_ca_system_score_codex":0.00037222705,"about_ca_system_score_gemma":0.00053165987,"threshold_uncertainty_score":0.0074742436},"labels":[],"label_agreement":null},{"id":"W2299666588","doi":"10.1007/s13318-016-0322-9","title":"Pharmacokinetic Time Course Scaling of a Subcutaneously Administered Pegylated Peptide Conjugate for a First-in-Human Investigation","year":2016,"lang":"en","type":"article","venue":"European Journal of Drug Metabolism and Pharmacokinetics","topic":"Advancements in Transdermal Drug Delivery","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Waterloo","funders":"","keywords":"Pharmacokinetics; Human physiology; Conjugate; Peptide; Clinical chemistry; Pharmacology; Medicine; PEGylation; Medical physics; Chemistry; Internal medicine; Biochemistry; Mathematics; Polyethylene glycol","score_opus":0.05078384283950307,"score_gpt":0.36189093232493424,"score_spread":0.3111070894854312,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2299666588","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.992965,0.0009957495,0.0037511482,0.00011830429,0.00011971343,0.00018482067,0.00061880227,0.00012266998,0.0011238526],"genre_scores_gemma":[0.99453354,0.000590351,0.0019700213,0.000057810856,0.000019059471,0.000056453577,0.00033020385,0.00003679861,0.002405612],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998965,0.000020636113,0.0000045441984,0.00003336882,0.000022570292,0.00002241465],"domain_scores_gemma":[0.9998357,0.000044373395,0.000034961195,0.000026731417,0.000028485501,0.000029686436],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002926736,0.0002736481,0.00024291093,0.00012669765,0.00011888271,0.0002977006,0.0001675984,0.00026221358,0.0016747246],"category_scores_gemma":[0.00047386676,0.00015876848,0.0002697892,0.00013785456,0.00017437049,0.00021858714,0.00007439572,0.00061618234,0.0004474903],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.012584193,0.0022368014,0.0017234681,0.00013596463,0.00007191277,0.00022533764,0.0001906283,0.0021850723,0.9354005,0.00021082928,0.0013487266,0.043686554],"study_design_scores_gemma":[0.00078223913,0.057913758,0.0215312,0.000021264002,0.00023565526,0.00084863126,0.00010759892,0.015843479,0.89214826,0.0001628648,0.010353033,0.000051951163],"about_ca_topic_score_codex":0.0007222291,"about_ca_topic_score_gemma":0.00086897775,"teacher_disagreement_score":0.0016747246,"about_ca_system_score_codex":0.00020335773,"about_ca_system_score_gemma":0.0003880319,"threshold_uncertainty_score":0.005602479},"labels":[],"label_agreement":null},{"id":"W2403613290","doi":"10.1007/s13318-016-0348-z","title":"Proposing the Use of Partial AUC as an Adjunctive Measure in Establishing Bioequivalence Between Deltoid and Gluteal Administration of Long-Acting Injectable Antipsychotics","year":2016,"lang":"en","type":"article","venue":"European Journal of Drug Metabolism and Pharmacokinetics","topic":"Pharmaceutical studies and practices","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Provincial Health Services Authority; University of British Columbia","funders":"Canadian Institutes of Health Research; BC Mental Health and Substance Use Services","keywords":"Bioequivalence; Pharmacokinetics; Medicine; Pharmacology; Plasma concentration; Area under the curve","score_opus":0.10475735469394125,"score_gpt":0.3581629305154335,"score_spread":0.25340557582149226,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2403613290","genre_codex":"methods","genre_gemma":"methods","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":"methods","domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.3979332,0.0052811992,0.57745546,0.005190753,0.00078488997,0.0009146348,0.0002679409,0.00072868593,0.011443208],"genre_scores_gemma":[0.86061656,0.0004254958,0.13710175,0.0006519451,0.0002272141,0.00021060274,0.00006777007,0.000052495358,0.0006459974],"study_design_codex":"design_other","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9623061,0.030669473,0.001495394,0.0020837153,0.0031161085,0.00032910059],"domain_scores_gemma":[0.9571834,0.03125033,0.0031348679,0.003486046,0.004369197,0.0005761993],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.036890257,0.00072000833,0.0013991232,0.0014123988,0.00061911397,0.0038627046,0.0014060731,0.0021416254,0.0008521687],"category_scores_gemma":[0.07881278,0.00045424467,0.0012315279,0.0011720535,0.0035704786,0.0034061845,0.0016829523,0.0031177935,0.00033094306],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011808634,0.00135102,0.12407917,0.0012559687,0.0020131245,0.0005931845,0.0020913715,0.01287894,0.057228267,0.07095225,0.002616105,0.7131319],"study_design_scores_gemma":[0.002148757,0.04823433,0.1415191,0.0008466181,0.004164775,0.0062627196,0.0016092379,0.48113036,0.130846,0.14138947,0.040974874,0.00087374344],"about_ca_topic_score_codex":0.0008462673,"about_ca_topic_score_gemma":0.0011533458,"teacher_disagreement_score":0.96310973,"about_ca_system_score_codex":0.0008065235,"about_ca_system_score_gemma":0.0030500584,"threshold_uncertainty_score":0.19509661},"labels":[],"label_agreement":null},{"id":"W2582578406","doi":"10.1007/s13318-016-0398-2","title":"Systemic Bioavailability and Dose Proportionality of Omega-3 Administered in Free Fatty Acid Form Compared With Ethyl Ester Form: Results of a Phase 1 Study in Healthy Volunteers","year":2017,"lang":"en","type":"article","venue":"European Journal of Drug Metabolism and Pharmacokinetics","topic":"Fatty Acid Research and Health","field":"Nursing","cited_by":12,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Celerion (Canada)","funders":"AstraZeneca","keywords":"Bioavailability; Eicosapentaenoic acid; Pharmacokinetics; Clinical chemistry; Docosahexaenoic acid; Dosing; Chemistry; Fatty acid; Ethyl ester; Medicine; Omega 3 fatty acid; Pharmacology; Animal science; Biochemistry; Polyunsaturated fatty acid; Biology; Organic chemistry","score_opus":0.05782530799352601,"score_gpt":0.3675605375013026,"score_spread":0.30973522950777654,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2582578406","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.997366,0.00068379915,0.00079208176,0.00005986749,0.000050318573,0.00031501966,0.00034070344,0.000060350387,0.00033184045],"genre_scores_gemma":[0.99494594,0.0006573165,0.0011200667,0.0001635633,0.00013764206,0.00027094377,0.00051121216,0.00008470893,0.0021085571],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99917287,0.00036639144,0.00003885585,0.00023644068,0.00007676025,0.000108763685],"domain_scores_gemma":[0.99817705,0.0007000032,0.00037286783,0.0002877148,0.00014480307,0.0003174533],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017159816,0.0012858264,0.0018202325,0.000489672,0.00055957836,0.0007831734,0.00069541665,0.0014489873,0.0041404436],"category_scores_gemma":[0.0025294842,0.0010695704,0.0013487096,0.00042094666,0.0015021446,0.0012901317,0.00033448485,0.0023807043,0.0009426591],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8572543,0.016700381,0.0031170335,0.0002209959,0.00041627543,0.00016276361,0.00039044363,0.0008873579,0.09954591,0.00008246075,0.00045150798,0.020770693],"study_design_scores_gemma":[0.10814536,0.7610832,0.052737806,0.000027234266,0.0012964956,0.0004570186,0.0002589351,0.003499445,0.07066611,0.0003085454,0.0013969707,0.00012285056],"about_ca_topic_score_codex":0.0018645631,"about_ca_topic_score_gemma":0.0014852236,"teacher_disagreement_score":0.0041404436,"about_ca_system_score_codex":0.0005397859,"about_ca_system_score_gemma":0.0008667343,"threshold_uncertainty_score":0.013851166},"labels":[],"label_agreement":null},{"id":"W2766243414","doi":"10.1007/s13318-017-0440-z","title":"Safety, Tolerability and Pharmacokinetics of Oral BI 425809, a Glycine Transporter 1 Inhibitor, in Healthy Male Volunteers: A Partially Randomised, Single-Blind, Placebo-Controlled, First-in-Human Study","year":2017,"lang":"en","type":"article","venue":"European Journal of Drug Metabolism and Pharmacokinetics","topic":"Amino Acid Enzymes and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":37,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Boehringer Ingelheim (Canada)","funders":"","keywords":"Pharmacokinetics; Tolerability; Pharmacology; NMDA receptor; Placebo; Adverse effect; Medicine; Bioavailability; Oral administration; Internal medicine; Endocrinology; Receptor","score_opus":0.018815103319660586,"score_gpt":0.2862118875924309,"score_spread":0.2673967842727703,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2766243414","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9948154,0.0012212974,0.000610401,0.0000848647,0.00006864778,0.001777262,0.00062574085,0.00007944053,0.00071690726],"genre_scores_gemma":[0.9917891,0.0013825536,0.0011435883,0.0003827651,0.0001974508,0.0018716021,0.0007707801,0.00003700704,0.002425106],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99905044,0.0004779393,0.00007316502,0.00017264443,0.00011021648,0.00011566131],"domain_scores_gemma":[0.9991505,0.00015934568,0.00021778209,0.00009948374,0.0000927317,0.00028013633],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019585926,0.001526183,0.0028184403,0.00046615416,0.00051334494,0.0008353927,0.00063475344,0.0014317516,0.0044986936],"category_scores_gemma":[0.0015133662,0.0010240191,0.0011094407,0.0004714482,0.0011670047,0.00088973914,0.00036100796,0.0014639219,0.001405883],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.91228884,0.023407837,0.0019324131,0.0005655466,0.00075432326,0.00012109374,0.00017272518,0.0002889016,0.040183213,0.000046644673,0.0005514159,0.019687066],"study_design_scores_gemma":[0.28796443,0.68396187,0.019712558,0.0000261749,0.0011197241,0.00016943706,0.000080303296,0.00068023923,0.0048367195,0.000088532244,0.001306319,0.000053679294],"about_ca_topic_score_codex":0.000853051,"about_ca_topic_score_gemma":0.0011524338,"teacher_disagreement_score":0.0044986936,"about_ca_system_score_codex":0.00048627183,"about_ca_system_score_gemma":0.00085698237,"threshold_uncertainty_score":0.015049636},"labels":[],"label_agreement":null},{"id":"W2790570760","doi":"10.1007/s13318-018-0471-0","title":"Clinical Pharmacokinetics and Drug–Drug Interactions of Elbasvir/Grazoprevir","year":2018,"lang":"en","type":"article","venue":"European Journal of Drug Metabolism and Pharmacokinetics","topic":"Hepatitis C virus research","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Pharmacokinetics; Pharmacology; Drug interaction; Drug; Internal medicine","score_opus":0.04938803418078314,"score_gpt":0.3939503694461836,"score_spread":0.3445623352654005,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2790570760","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98752964,0.008044538,0.00056014885,0.00023368969,0.000045513665,0.00004578196,0.00017714725,0.000053474123,0.003310009],"genre_scores_gemma":[0.9984328,0.0005340312,0.00021802698,0.00007423671,0.000019367795,0.000007950847,0.000086046304,0.000009092717,0.00061827677],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9988587,0.00064986484,0.000060261253,0.00012849102,0.00020265473,0.00009999793],"domain_scores_gemma":[0.9990225,0.00042229137,0.00018910026,0.000055132223,0.00014044726,0.00017058957],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015616391,0.00032573598,0.00048231796,0.0003382423,0.00025947372,0.00069376675,0.0002122977,0.00048677716,0.002228398],"category_scores_gemma":[0.0042615375,0.00026628384,0.0004824366,0.00021756557,0.00036176748,0.00055771635,0.0001964183,0.00090409175,0.0004912159],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.2064419,0.0036281974,0.21401234,0.00079634355,0.0034344431,0.0023020639,0.00086641184,0.011135887,0.15046579,0.0014969427,0.003927396,0.4014923],"study_design_scores_gemma":[0.006672002,0.054114155,0.8062714,0.00021724071,0.0029638158,0.0107878875,0.00086738134,0.024423452,0.06368473,0.0013389844,0.028443638,0.00021534199],"about_ca_topic_score_codex":0.0013210004,"about_ca_topic_score_gemma":0.0016133169,"teacher_disagreement_score":0.002228398,"about_ca_system_score_codex":0.00088314345,"about_ca_system_score_gemma":0.00050082663,"threshold_uncertainty_score":0.00825882},"labels":[],"label_agreement":null},{"id":"W2896125532","doi":"10.1007/s13318-018-0520-8","title":"Clinical Pharmacokinetics and Pharmacodynamics of Delafloxacin","year":2018,"lang":"en","type":"review","venue":"European Journal of Drug Metabolism and Pharmacokinetics","topic":"Antibiotics Pharmacokinetics and Efficacy","field":"Medicine","cited_by":31,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta; Alberta Health Services","funders":"","keywords":"Medicine; Pharmacology; Pharmacokinetics; Pharmacodynamics; Chronic bronchitis; Drug; Bioavailability; Acute Pharyngitis; In vivo; Internal medicine; Pharyngitis","score_opus":0.05655088689311385,"score_gpt":0.38965559840787034,"score_spread":0.3331047115147565,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2896125532","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0006509288,0.99855286,0.00012197127,0.00016928188,0.000035806825,0.0000041059598,0.00002403271,0.0000047542335,0.00043634896],"genre_scores_gemma":[0.0072678607,0.9914317,0.00032936083,0.00026077905,0.0000990425,0.000009423266,0.00005955869,0.000002122589,0.00054017006],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9997482,0.000054788772,0.000060865645,0.00003768153,0.000080242266,0.000018194298],"domain_scores_gemma":[0.9995333,0.00023344577,0.00013315566,0.000008782056,0.00007248169,0.000018788016],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006668742,0.00056807103,0.0014487691,0.0013022126,0.00011117087,0.0007581598,0.0005593699,0.00067682966,0.0019285951],"category_scores_gemma":[0.00085558515,0.00025252334,0.0007464671,0.00095786003,0.00035668473,0.00074349385,0.00032250505,0.0012184932,0.00048051408],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00058910216,0.00012947991,0.00080225343,0.021926394,0.00031776706,0.0003465948,0.000069618145,0.00046960555,0.0043006553,0.0010412943,0.009354374,0.9606527],"study_design_scores_gemma":[0.00039765198,0.0015593341,0.008850986,0.010259049,0.0022266344,0.009883706,0.00025306968,0.00076662446,0.007610671,0.0020309247,0.9560553,0.00010616934],"about_ca_topic_score_codex":0.0011738547,"about_ca_topic_score_gemma":0.002137968,"teacher_disagreement_score":0.0019285951,"about_ca_system_score_codex":0.00050163886,"about_ca_system_score_gemma":0.00083122205,"threshold_uncertainty_score":0.0064517856},"labels":[],"label_agreement":null},{"id":"W2899367089","doi":"10.1007/s13318-018-0525-3","title":"Population Pharmacokinetic Analysis of Immediate-Release Oral Tacrolimus Co-administered with Mycophenolate Mofetil in Corticosteroid-Free Adult Kidney Transplant Recipients","year":2018,"lang":"en","type":"article","venue":"European Journal of Drug Metabolism and Pharmacokinetics","topic":"Renal Transplantation Outcomes and Treatments","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; University of British Columbia; University of Alberta","funders":"Vancouver Coastal Health Research Institute; F. Hoffmann-La Roche","keywords":"Tacrolimus; Mycophenolic acid; Pharmacokinetics; Population; Medicine; Calcineurin; Pharmacology; Mycophenolate; Renal function; Corticosteroid; Therapeutic drug monitoring; Kidney transplantation; Transplantation; Urology; Internal medicine","score_opus":0.01677122219796305,"score_gpt":0.29372074571092094,"score_spread":0.2769495235129579,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2899367089","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99962556,0.000071695744,0.00014642357,0.000010422932,0.000002283093,0.000004858522,0.00004149487,0.0000066507882,0.000090537236],"genre_scores_gemma":[0.9996898,0.000028587065,0.00007647888,0.000016399052,0.000005961281,0.00000449713,0.00010457541,0.0000033440394,0.0000704717],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9994367,0.00018778989,0.000040087732,0.00014355929,0.00010245669,0.00008948721],"domain_scores_gemma":[0.99898344,0.0003908817,0.00029826403,0.00012781432,0.00006813403,0.00013140932],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008060041,0.00036017862,0.00070339744,0.00028168553,0.00020375737,0.00071915594,0.0002935228,0.00045636724,0.00089784304],"category_scores_gemma":[0.0021203856,0.0002281551,0.00092633895,0.0003412355,0.00027507526,0.0005525353,0.00028109478,0.0007732132,0.00016042187],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.05207816,0.0020225954,0.883945,0.00010876523,0.0029237636,0.0014011912,0.00043396096,0.004428876,0.018923163,0.00030879228,0.00066888257,0.032756813],"study_design_scores_gemma":[0.00045624885,0.009911325,0.97398335,0.000008297138,0.0011119901,0.0015299004,0.00025058666,0.009996842,0.0019507037,0.0002183087,0.00053230574,0.000050014674],"about_ca_topic_score_codex":0.0010129773,"about_ca_topic_score_gemma":0.00072889245,"teacher_disagreement_score":0.0010129773,"about_ca_system_score_codex":0.0004312293,"about_ca_system_score_gemma":0.0003793871,"threshold_uncertainty_score":0.004262626},"labels":[],"label_agreement":null},{"id":"W2903610462","doi":"10.1007/s13318-018-0533-3","title":"Advanced In Vitro HepaRG Culture Systems for Xenobiotic Metabolism and Toxicity Characterization","year":2018,"lang":"en","type":"review","venue":"European Journal of Drug Metabolism and Pharmacokinetics","topic":"Liver physiology and pathology","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta; Health Sciences Centre","funders":"","keywords":"Toxicity; Drug metabolism; Scaffold; Spheroid; In vitro; 3D cell culture; Xenobiotic; Cell biology; Cellular model; Function (biology); Pregnane X receptor; Biology; Cell culture; Pharmacology; Chemistry; Computational biology; Drug; Biochemistry; Biomedical engineering; Nuclear receptor; Medicine","score_opus":0.02906675438507547,"score_gpt":0.3145566897358853,"score_spread":0.2854899353508098,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2903610462","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0022251122,0.9903182,0.0034556482,0.0003564354,0.00028080732,0.000030138883,0.0001346144,0.000042484444,0.0031566704],"genre_scores_gemma":[0.0065488215,0.9876138,0.0025606463,0.00022675925,0.00014451395,0.000023679635,0.00019804132,0.0000062721097,0.00267749],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99985456,0.000024327668,0.000024898456,0.000017544584,0.00006488505,0.000013786421],"domain_scores_gemma":[0.9998136,0.00006578395,0.000039157996,0.000011630575,0.00005809168,0.000011758271],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00041808665,0.00067965273,0.00066087185,0.0011744295,0.00011037538,0.00062635745,0.00039045513,0.000423452,0.0016405548],"category_scores_gemma":[0.00034844043,0.00016955928,0.0003245918,0.0009394067,0.00023995577,0.0006312639,0.00043706,0.00067953975,0.0007525592],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010307845,0.000089216235,0.0004509389,0.008508569,0.000086001666,0.00030667835,0.00005051353,0.0005145829,0.02615176,0.002338759,0.0074669328,0.953933],"study_design_scores_gemma":[0.000017834374,0.00024428702,0.0020353051,0.0013970401,0.00028022553,0.0020283223,0.000060418297,0.00037475134,0.029567163,0.0013675843,0.9625932,0.00003384831],"about_ca_topic_score_codex":0.00064551755,"about_ca_topic_score_gemma":0.0013647382,"teacher_disagreement_score":0.0016405548,"about_ca_system_score_codex":0.00027787514,"about_ca_system_score_gemma":0.0006343551,"threshold_uncertainty_score":0.005488217},"labels":[],"label_agreement":null},{"id":"W2941839579","doi":"10.1007/s13318-019-00553-z","title":"Predictability of Capillary Blood Spot Toward Venous Whole Blood Sampling for Therapeutic Drug Monitoring of Tacrolimus in Solid Organ Transplant Recipients","year":2019,"lang":"en","type":"review","venue":"European Journal of Drug Metabolism and Pharmacokinetics","topic":"Biosimilars and Bioanalytical Methods","field":"Immunology and Microbiology","cited_by":8,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Health Services; University of Alberta","funders":"","keywords":"Tacrolimus; Therapeutic drug monitoring; Medicine; Drug; Dried blood spot; Whole blood; Organ transplantation; Intensive care medicine; Venous blood; Internal medicine; Pharmacology; Transplantation; Chemistry; Chromatography","score_opus":0.07249983486276743,"score_gpt":0.34793842134482544,"score_spread":0.275438586482058,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2941839579","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0012482333,0.99609995,0.0011680889,0.00037234966,0.00028580747,0.0000099132485,0.000047658752,0.000015900718,0.0007520767],"genre_scores_gemma":[0.016901333,0.9770592,0.0030866447,0.00084178965,0.00084601896,0.0000337946,0.0001594598,0.000012601847,0.0010592947],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9993311,0.00014856739,0.00008272175,0.0001641157,0.000247787,0.000025750085],"domain_scores_gemma":[0.99829847,0.0011153212,0.00021147402,0.00003750533,0.00029708698,0.000040253813],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019543858,0.0007228946,0.0013703515,0.0010545618,0.00008919254,0.0010069985,0.0009854612,0.0008854188,0.00109618],"category_scores_gemma":[0.002646552,0.0002504832,0.000627001,0.0007842477,0.00051401503,0.00071065576,0.00038650513,0.0013254969,0.0006694507],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003004529,0.00007851488,0.0017035792,0.004198437,0.00016783962,0.00010891484,0.000027362692,0.00032334507,0.0025250125,0.0010508721,0.005510487,0.9840051],"study_design_scores_gemma":[0.000366482,0.0029289387,0.04065594,0.009757134,0.0026660915,0.0077218525,0.0002710126,0.0053969105,0.029731737,0.008863497,0.89134383,0.00029650144],"about_ca_topic_score_codex":0.0007293747,"about_ca_topic_score_gemma":0.0010835305,"teacher_disagreement_score":0.0019543858,"about_ca_system_score_codex":0.00041112708,"about_ca_system_score_gemma":0.0008696321,"threshold_uncertainty_score":0.010335922},"labels":[],"label_agreement":null},{"id":"W2998860412","doi":"10.1007/s13318-019-00601-8","title":"Is Therapeutic Drug Monitoring of Lacosamide Needed in Patients with Seizures and Epilepsy?","year":2020,"lang":"en","type":"review","venue":"European Journal of Drug Metabolism and Pharmacokinetics","topic":"Pharmacological Effects and Toxicity Studies","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Lacosamide; Medicine; Pharmacokinetics; Pharmacology; Therapeutic drug monitoring; Carbamazepine; Phenytoin; Drug; Epilepsy; Intensive care medicine; Psychiatry","score_opus":0.03703921092062795,"score_gpt":0.32222124884068354,"score_spread":0.2851820379200556,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2998860412","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0005136328,0.9983253,0.00013623368,0.00048658586,0.000100134865,0.0000041524504,0.000022664919,0.0000051629113,0.00040610664],"genre_scores_gemma":[0.0068229986,0.99094665,0.00054002315,0.0011438496,0.0002595486,0.000011897726,0.000067814835,0.0000034639813,0.00020379416],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9996351,0.00011032696,0.000087001405,0.00005408695,0.00009029726,0.00002317208],"domain_scores_gemma":[0.99898785,0.0005422616,0.0002868341,0.00001638213,0.00012509004,0.00004150412],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011181297,0.0005321438,0.0027301656,0.0006850202,0.000116941315,0.0009085897,0.00078415876,0.0009894953,0.0019324889],"category_scores_gemma":[0.0022360703,0.00017076888,0.0010141124,0.001061763,0.0004298765,0.0010490083,0.0003051653,0.0015541391,0.00051658857],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009146086,0.000044462056,0.00077292405,0.018490717,0.0004886945,0.00031009177,0.00004517378,0.00018661583,0.0013173391,0.00093157205,0.008391939,0.968106],"study_design_scores_gemma":[0.0019898657,0.0015710267,0.01581119,0.04294122,0.006448951,0.009393989,0.00041294898,0.0008021801,0.0025755253,0.0049555814,0.9129609,0.00013661252],"about_ca_topic_score_codex":0.0013025686,"about_ca_topic_score_gemma":0.0036547831,"teacher_disagreement_score":0.0027301656,"about_ca_system_score_codex":0.000523898,"about_ca_system_score_gemma":0.0011013425,"threshold_uncertainty_score":0.006464839},"labels":[],"label_agreement":null},{"id":"W3010713619","doi":"10.1007/s13318-020-00613-9","title":"An Open-Label, Randomized, Single-Dose, Crossover, Comparative Pharmacokinetics Study of YLB113 and the Etanercept Reference Product in Healthy Adult Male Subjects","year":2020,"lang":"en","type":"article","venue":"European Journal of Drug Metabolism and Pharmacokinetics","topic":"Immune Cell Function and Interaction","field":"Immunology and Microbiology","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Trillium Therapeutics (Canada)","funders":"Mylan","keywords":"Etanercept; Bioequivalence; Pharmacokinetics; Medicine; Crossover study; Rheumatoid arthritis; Cmax; Adverse effect; Pharmacology; Bioavailability; Area under the curve; Internal medicine; Placebo; Pathology","score_opus":0.05813416649355184,"score_gpt":0.3227903275896076,"score_spread":0.2646561610960557,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3010713619","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99456066,0.00038287576,0.0010129387,0.00007120578,0.00012415383,0.0028971322,0.00038689133,0.000051608433,0.0005124984],"genre_scores_gemma":[0.99009997,0.0004106543,0.0025878581,0.0004284827,0.00041331776,0.0036880635,0.000629418,0.0000278963,0.001714332],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.997445,0.0012756826,0.00018107025,0.0005033256,0.00032520213,0.0002696982],"domain_scores_gemma":[0.99702615,0.00072726875,0.0005944615,0.00040367118,0.0002918928,0.0009565184],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0050110044,0.0018699719,0.0037154425,0.00067513145,0.00071139104,0.0009662027,0.0009185016,0.0018830406,0.0041008894],"category_scores_gemma":[0.0034327344,0.0012407233,0.0014149057,0.00060910784,0.0020888317,0.0017390448,0.00053658395,0.0025063097,0.001130387],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9199033,0.05375257,0.0014315818,0.00015027355,0.00029364278,0.000055144912,0.00014910441,0.0002489876,0.014467237,0.00007692333,0.00022419008,0.009246972],"study_design_scores_gemma":[0.27529386,0.7134172,0.008237393,0.0000067917636,0.0002533998,0.00006318282,0.000047464302,0.00060503714,0.0014958427,0.00007616014,0.00047281312,0.00003086229],"about_ca_topic_score_codex":0.0008488202,"about_ca_topic_score_gemma":0.0009091062,"teacher_disagreement_score":0.0050110044,"about_ca_system_score_codex":0.0006623129,"about_ca_system_score_gemma":0.0014687189,"threshold_uncertainty_score":0.02650106},"labels":[],"label_agreement":null},{"id":"W3103380217","doi":"10.1007/s13318-020-00657-x","title":"Clinical Pharmacokinetics and Pharmacodynamics of Anti-Tubercular Drugs in Pregnancy","year":2020,"lang":"en","type":"review","venue":"European Journal of Drug Metabolism and Pharmacokinetics","topic":"Tuberculosis Research and Epidemiology","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta; University of Alberta Hospital","funders":"","keywords":"Medicine; Pharmacokinetics; Observational study; Pregnancy; Intensive care medicine; Drug; MEDLINE; Population; Pharmacology; Drugs in pregnancy; Tuberculosis; Internal medicine; Fetus; Pathology","score_opus":0.05753270301240759,"score_gpt":0.4023705688796793,"score_spread":0.3448378658672717,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3103380217","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000105395346,0.99953294,0.000054855915,0.000097401076,0.00002970055,0.0000016213514,0.000009883028,0.0000021432986,0.00016610169],"genre_scores_gemma":[0.0009870628,0.9986243,0.00010090157,0.0000843422,0.00008003329,0.0000040618215,0.000015740563,6.422091e-7,0.00010284478],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9997454,0.00006595446,0.000050344468,0.000042334865,0.00007951068,0.000016500006],"domain_scores_gemma":[0.9990024,0.0006842366,0.0001760357,0.00001438594,0.00009363355,0.000029374896],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00080704316,0.0007015346,0.0019141774,0.0014196848,0.00011358596,0.0007611484,0.000736537,0.00085672183,0.0021756317],"category_scores_gemma":[0.001884346,0.0002685584,0.00063054386,0.0018073139,0.00035751655,0.0006653081,0.00038482677,0.0013664998,0.0007483859],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00024072792,0.000082927974,0.00056035403,0.01886962,0.0002766523,0.00019012242,0.000029648225,0.0004838288,0.00084455713,0.001026708,0.0076077003,0.96978724],"study_design_scores_gemma":[0.00032811344,0.0008333939,0.010442964,0.022392737,0.002393607,0.007009793,0.00013951737,0.0008209962,0.0019133951,0.0041574314,0.9494573,0.0001107093],"about_ca_topic_score_codex":0.0012522825,"about_ca_topic_score_gemma":0.0017711113,"teacher_disagreement_score":0.0021756317,"about_ca_system_score_codex":0.00056030584,"about_ca_system_score_gemma":0.0009226253,"threshold_uncertainty_score":0.007278204},"labels":[],"label_agreement":null},{"id":"W3114373673","doi":"10.1007/s13318-020-00666-w","title":"Parameterization of Microsomal and Cytosolic Scaling Factors: Methodological and Biological Considerations for Scalar Derivation and Validation","year":2020,"lang":"en","type":"article","venue":"European Journal of Drug Metabolism and Pharmacokinetics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":10,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia Hospital; University of British Columbia","funders":"Natural Sciences and Engineering Research Council of Canada; Genentech","keywords":"Microsome; Cytosol; Biochemistry; Biology; Enzyme kinetics; Enzyme; Computational biology","score_opus":0.3040208151044591,"score_gpt":0.41808110510860486,"score_spread":0.11406029000414575,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3114373673","genre_codex":"methods","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":"methods","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0067443647,0.00033415342,0.9907767,0.00026544512,0.00007089274,0.00008633354,0.00012509787,0.00046039087,0.0011366488],"genre_scores_gemma":[0.30122364,0.00082719664,0.69393164,0.00043767152,0.00016853251,0.00059403805,0.00052948634,0.0010454712,0.0012422537],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99429893,0.003092714,0.0005209097,0.0007231101,0.0012003934,0.00016388243],"domain_scores_gemma":[0.961237,0.025450593,0.0017180743,0.0073803486,0.0039666267,0.00024735022],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.019707933,0.0016846884,0.001321101,0.0015340896,0.00092839723,0.0037217475,0.0024676837,0.0016620972,0.0022009518],"category_scores_gemma":[0.104997,0.00060880487,0.0013011707,0.001771232,0.0016909465,0.0034836594,0.0025239608,0.0037947728,0.0008547612],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00035605018,0.00032896316,0.008769009,0.00156097,0.0004384509,0.00040243226,0.0008066045,0.28388843,0.05714298,0.366823,0.0043532895,0.2751299],"study_design_scores_gemma":[0.00005181669,0.00015613208,0.0042939074,0.00027058576,0.00011052761,0.00027206607,0.0001517928,0.8109728,0.027563745,0.14430404,0.011706753,0.00014594014],"about_ca_topic_score_codex":0.0041995468,"about_ca_topic_score_gemma":0.0025860379,"teacher_disagreement_score":0.019707933,"about_ca_system_score_codex":0.0013691025,"about_ca_system_score_gemma":0.0021584642,"threshold_uncertainty_score":0.10422677},"labels":[],"label_agreement":null},{"id":"W3129001574","doi":"10.1007/s13318-020-00661-1","title":"Feasibility of Using Oral Fluid for Therapeutic Drug Monitoring of Antiepileptic Drugs","year":2021,"lang":"en","type":"review","venue":"European Journal of Drug Metabolism and Pharmacokinetics","topic":"Epilepsy research and treatment","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Lacosamide; Lamotrigine; Therapeutic drug monitoring; Oxcarbazepine; Levetiracetam; Carbamazepine; Topiramate; Primidone; Valproic Acid; Epilepsy; Phenytoin; Intensive care medicine; Pharmacology; Drug; Psychiatry","score_opus":0.13362715905784622,"score_gpt":0.42060617591100713,"score_spread":0.2869790168531609,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3129001574","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0008278364,0.9972234,0.0007061148,0.0002230014,0.0001335136,0.000009874025,0.000039313316,0.000011576726,0.00082544883],"genre_scores_gemma":[0.009148598,0.9878329,0.0016156823,0.00034311443,0.00023430047,0.000026907486,0.00009391984,0.0000055156443,0.00069905753],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9994685,0.00014043158,0.00006094741,0.00009261218,0.0002089569,0.000028441711],"domain_scores_gemma":[0.99925953,0.0004309273,0.00013443272,0.000018195487,0.00013461529,0.000022252432],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011605446,0.0010062731,0.002159884,0.0014446451,0.000109811306,0.0014396132,0.0009436417,0.0011954443,0.001507781],"category_scores_gemma":[0.0013924,0.00024478298,0.00079104403,0.0009335886,0.00055714784,0.0014161809,0.0006286315,0.0015759239,0.0008069251],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00038044268,0.00009951157,0.00053436344,0.010655776,0.00019955121,0.00020492148,0.000033623946,0.00029936366,0.0063269846,0.0018731994,0.0041265087,0.97526574],"study_design_scores_gemma":[0.0003432284,0.0015146981,0.008293618,0.006915334,0.001369632,0.005404063,0.00016323426,0.0014014493,0.021635454,0.0039765444,0.94884676,0.00013592624],"about_ca_topic_score_codex":0.00081504945,"about_ca_topic_score_gemma":0.00087130844,"teacher_disagreement_score":0.002159884,"about_ca_system_score_codex":0.00043425366,"about_ca_system_score_gemma":0.00082377344,"threshold_uncertainty_score":0.0061376095},"labels":[],"label_agreement":null},{"id":"W3168209064","doi":"10.1007/s13318-021-00691-3","title":"Comparison of Various Approaches to Translate Non-Linear Pharmacokinetics of Monoclonal Antibodies from Cynomolgus Monkey to Human","year":2021,"lang":"en","type":"article","venue":"European Journal of Drug Metabolism and Pharmacokinetics","topic":"Monoclonal and Polyclonal Antibodies Research","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"National Research Council Canada","funders":"","keywords":"Pharmacokinetics; Monoclonal antibody; Allometry; Linear model; Pharmacology; Computational biology; Biology; Mathematics; Antibody; Statistics; Immunology","score_opus":0.1120842642260087,"score_gpt":0.372265443825211,"score_spread":0.2601811795992023,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3168209064","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6670187,0.008088124,0.31392464,0.00035571234,0.0004187684,0.001076844,0.0013000671,0.001722038,0.0060951654],"genre_scores_gemma":[0.82658285,0.005008479,0.15693876,0.00033292925,0.00010207731,0.0010541824,0.0015334125,0.0008265231,0.0076207793],"study_design_codex":"bench_or_experimental","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.998965,0.00037927876,0.000058018577,0.00020840397,0.00027464132,0.00011471345],"domain_scores_gemma":[0.99889636,0.00058796944,0.00015102701,0.0001275207,0.0001968862,0.000040286217],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0020195278,0.0007489167,0.0006792105,0.000784448,0.0002862222,0.0011832792,0.0004941139,0.00046805514,0.0019052913],"category_scores_gemma":[0.0041321153,0.00039590886,0.0007940756,0.00062871183,0.00039724508,0.0003902129,0.00034992964,0.0010838266,0.00062786153],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005252374,0.0006617011,0.003299233,0.0009079755,0.00042932446,0.00014332362,0.00032819182,0.007851667,0.85426056,0.0025073916,0.0009179953,0.123440206],"study_design_scores_gemma":[0.00021087774,0.0033830204,0.007433831,0.000035884324,0.00041665565,0.00054590404,0.00009566488,0.024911873,0.9543218,0.0007784175,0.0077999174,0.000066199194],"about_ca_topic_score_codex":0.0027159294,"about_ca_topic_score_gemma":0.0040635383,"teacher_disagreement_score":0.0027159294,"about_ca_system_score_codex":0.001226171,"about_ca_system_score_gemma":0.0011726008,"threshold_uncertainty_score":0.0106803775},"labels":[],"label_agreement":null},{"id":"W3182651484","doi":"10.1007/s13318-021-00699-9","title":"Novel Synthetic Analogues of 19(S/R)-Hydroxyeicosatetraenoic Acid Exhibit Noncompetitive Inhibitory Effect on the Activity of Cytochrome P450 1A1 and 1B1","year":2021,"lang":"en","type":"article","venue":"European Journal of Drug Metabolism and Pharmacokinetics","topic":"Eicosanoids and Hypertension Pharmacology","field":"Biochemistry, Genetics and Molecular Biology","cited_by":9,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"Canadian Institutes of Health Research","keywords":"Hydroxyeicosatetraenoic acid; Inhibitory postsynaptic potential; Cytochrome P450; Chemistry; Stereochemistry; Clinical chemistry; Pharmacology; Biochemistry; Arachidonic acid; Biology; Endocrinology; Enzyme","score_opus":0.012567622099569133,"score_gpt":0.24786859632867014,"score_spread":0.235300974229101,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3182651484","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9890387,0.0035165576,0.003131043,0.00015025021,0.0002077342,0.00009371854,0.0004782776,0.000056190678,0.0033274977],"genre_scores_gemma":[0.9891517,0.0022221967,0.0033730967,0.00015972662,0.00009851523,0.000054044478,0.0009432957,0.000020342102,0.0039770175],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99984765,0.000036161066,0.00001908546,0.000023643828,0.00003102554,0.0000424705],"domain_scores_gemma":[0.9997925,0.000040026127,0.000048101945,0.000018574368,0.00002697086,0.00007382714],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020947825,0.00028976554,0.00040289367,0.0002193364,0.00017837333,0.00021203188,0.00040514057,0.00036039398,0.003908416],"category_scores_gemma":[0.00029200187,0.0001684851,0.0003041397,0.00017376569,0.00022198966,0.00024781295,0.00015715399,0.0005987355,0.000728616],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018765157,0.00021922472,0.0001487861,0.0000655497,0.000028894023,0.00036262884,0.00001997028,0.00022305171,0.99311537,0.0002772878,0.00010615533,0.0035566061],"study_design_scores_gemma":[0.0004993526,0.007012619,0.0027187685,0.000012131773,0.00007832731,0.0015246533,0.000040365994,0.0008183338,0.9779708,0.000094191615,0.009209597,0.000020815643],"about_ca_topic_score_codex":0.00046240122,"about_ca_topic_score_gemma":0.0008645785,"teacher_disagreement_score":0.003908416,"about_ca_system_score_codex":0.00025367487,"about_ca_system_score_gemma":0.00025518617,"threshold_uncertainty_score":0.013074994},"labels":[],"label_agreement":null},{"id":"W3209630012","doi":"10.1007/s13318-021-00723-y","title":"Effects of Cytochrome P450 3A4 Induction and Inhibition on the Pharmacokinetics of BI 425809, a Novel Glycine Transporter 1 Inhibitor","year":2021,"lang":"en","type":"article","venue":"European Journal of Drug Metabolism and Pharmacokinetics","topic":"Amino Acid Enzymes and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Boehringer Ingelheim (Canada)","funders":"Boehringer Ingelheim","keywords":"Pharmacology; Pharmacokinetics; Cmax; CYP3A4; Itraconazole; Rifampicin; Oral administration; Chemistry; Cytochrome P450; Medicine; Internal medicine; Metabolism; Biochemistry; Antibiotics","score_opus":0.00952196338194641,"score_gpt":0.23058577654593843,"score_spread":0.221063813163992,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3209630012","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9959895,0.0010988368,0.0008809456,0.000070079135,0.000031765438,0.0001885206,0.00031084992,0.000066457884,0.0013628751],"genre_scores_gemma":[0.9955148,0.00056749844,0.0011047526,0.000052743162,0.000014130014,0.0002022743,0.00032713468,0.00001772923,0.0021989474],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99971646,0.000110448906,0.000018738665,0.000068665664,0.000038668444,0.00004709485],"domain_scores_gemma":[0.99987614,0.000024676243,0.000032481097,0.000018083763,0.00001721574,0.00003140053],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003139533,0.0004037913,0.0005644366,0.00017863732,0.00023475479,0.00033244418,0.00017646477,0.00028380894,0.002126469],"category_scores_gemma":[0.00038937683,0.00028227727,0.00031360748,0.00023564618,0.00026951666,0.00023697324,0.00013625353,0.0006670598,0.0003584727],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.04455692,0.003114998,0.00228747,0.00027660973,0.00022770313,0.0001437036,0.00014606478,0.000648601,0.9177791,0.00019844397,0.0005968822,0.030023707],"study_design_scores_gemma":[0.005238119,0.16021901,0.066052645,0.000030250303,0.0006702986,0.00058054057,0.00022096871,0.0037532577,0.7538869,0.00023514328,0.009048155,0.000064768334],"about_ca_topic_score_codex":0.0013770038,"about_ca_topic_score_gemma":0.0037850244,"teacher_disagreement_score":0.002126469,"about_ca_system_score_codex":0.00034223846,"about_ca_system_score_gemma":0.00043618013,"threshold_uncertainty_score":0.007113695},"labels":[],"label_agreement":null},{"id":"W4249973290","doi":"10.1007/bf03190048","title":"Preface","year":2000,"lang":"en","type":"article","venue":"European Journal of Drug Metabolism and Pharmacokinetics","topic":"","field":"","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Saskatchewan","funders":"","keywords":"Human physiology; Medicine; Internal medicine","score_opus":0.014373154903693562,"score_gpt":0.25782973589456565,"score_spread":0.24345658099087208,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4249973290","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0012797161,0.016766071,0.008100934,0.042968865,0.48992112,0.00064995326,0.013568103,0.0016416287,0.42510357],"genre_scores_gemma":[0.006028151,0.0077502853,0.0031603226,0.010802228,0.05924123,0.00033877886,0.009848263,0.0009607769,0.90187],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9993031,0.0001044935,0.00005061266,0.00010672763,0.00038061282,0.000054409556],"domain_scores_gemma":[0.9927563,0.0011012943,0.00025343592,0.00056065613,0.004479531,0.000848834],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015958165,0.0009279502,0.000614207,0.0027224245,0.0017945016,0.0023151988,0.0010711822,0.0008041192,0.36255047],"category_scores_gemma":[0.01475227,0.00021032462,0.000525802,0.0014949598,0.00040122087,0.0017443632,0.0016461782,0.0024224655,0.24714641],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00002108962,0.000011879904,0.0000666768,0.0000666001,0.0000014839113,0.000030387502,0.000021865248,0.00003637397,0.00007574555,0.0015359086,0.9673474,0.030784603],"study_design_scores_gemma":[0.0000036065965,0.000010381655,0.00023698632,0.00008912092,0.0000019085637,0.000042168507,0.000029976152,0.000022932783,0.000098427314,0.0015801861,0.9978807,0.0000035882317],"about_ca_topic_score_codex":0.0042233835,"about_ca_topic_score_gemma":0.0044902875,"teacher_disagreement_score":0.36255047,"about_ca_system_score_codex":0.0015173908,"about_ca_system_score_gemma":0.0019265403,"threshold_uncertainty_score":0},"labels":[],"label_agreement":null},{"id":"W4283646822","doi":"10.1007/s13318-022-00779-4","title":"Drug Dosing in Critically Ill Adult Patients with Augmented Renal Clearance","year":2022,"lang":"en","type":"review","venue":"European Journal of Drug Metabolism and Pharmacokinetics","topic":"Antibiotics Pharmacokinetics and Efficacy","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Dosing; Medicine; Intensive care medicine; MEDLINE; Meropenem; Therapeutic drug monitoring; Internal medicine; Drug; Pharmacology; Antibiotics","score_opus":0.020594148163452907,"score_gpt":0.2995362152240217,"score_spread":0.2789420670605688,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4283646822","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0010516471,0.9973707,0.00052231847,0.00028119993,0.00010990072,0.000008715077,0.000018899846,0.00001780743,0.000618764],"genre_scores_gemma":[0.012325054,0.9852365,0.0011035613,0.00051765505,0.0003017993,0.000019582209,0.000049874285,0.000005162008,0.00044083424],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9996655,0.00011154167,0.000076912795,0.000041079114,0.000088191635,0.00001682865],"domain_scores_gemma":[0.9994199,0.000298764,0.00019108207,0.00001298518,0.000058373633,0.000018851984],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00046934144,0.00057869893,0.001959938,0.00071927486,0.00008121818,0.0007433454,0.00053421606,0.0008169603,0.0011938529],"category_scores_gemma":[0.0014448941,0.00017794523,0.00058527495,0.00063276954,0.00022613857,0.0005802322,0.000336681,0.0013647595,0.00047967472],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007625066,0.0001017891,0.0006074979,0.015031093,0.0003997892,0.00032741626,0.000034442575,0.0007053015,0.0027312154,0.00082612614,0.0068931156,0.9715797],"study_design_scores_gemma":[0.001757975,0.0033642394,0.017594092,0.027751397,0.004255008,0.013507023,0.00018671929,0.0044953646,0.009906091,0.0059976336,0.91103244,0.00015198134],"about_ca_topic_score_codex":0.00038356555,"about_ca_topic_score_gemma":0.00072492904,"teacher_disagreement_score":0.001959938,"about_ca_system_score_codex":0.00025144196,"about_ca_system_score_gemma":0.0005325924,"threshold_uncertainty_score":0.003993809},"labels":[],"label_agreement":null},{"id":"W4380785854","doi":"10.1007/s13318-023-00835-7","title":"Early At-Home Measurement of Adalimumab Concentrations to Guide Anti-TNF Precision Dosing: A Pilot Study","year":2023,"lang":"en","type":"article","venue":"European Journal of Drug Metabolism and Pharmacokinetics","topic":"Biosimilars and Bioanalytical Methods","field":"Immunology and Microbiology","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Adalimumab; Medicine; Internal medicine; Pharmacokinetics; Population; Dosing; Gastroenterology; Rheumatoid arthritis","score_opus":0.05780076161012206,"score_gpt":0.3190729579071068,"score_spread":0.2612721962969848,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4380785854","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.992322,0.00027368905,0.0043747732,0.00011478314,0.00012638855,0.0011109096,0.0003205876,0.00015248788,0.0012044345],"genre_scores_gemma":[0.99213284,0.00017559736,0.0050267857,0.00036872044,0.00009629128,0.00077292166,0.00043318106,0.00005744477,0.0009362499],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.9983581,0.0007153996,0.00006818944,0.00036159763,0.00028338985,0.00021334423],"domain_scores_gemma":[0.997393,0.0007793711,0.00023883305,0.00055401016,0.00048603828,0.0005487068],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002260997,0.0014216149,0.0015314274,0.00032688052,0.0008576482,0.0011633309,0.0007760844,0.0015011316,0.0027013319],"category_scores_gemma":[0.0030907833,0.0004976089,0.0009142848,0.00031547,0.0012131013,0.00086593936,0.00068568374,0.0024476722,0.0011468518],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.41829482,0.13329557,0.07219009,0.00076264393,0.0009866292,0.0015626285,0.0027315186,0.0025642128,0.15860695,0.0005023471,0.0033315287,0.20517106],"study_design_scores_gemma":[0.031779874,0.7685985,0.10009377,0.000099606405,0.0014758854,0.0018492616,0.0008876256,0.007799382,0.079306215,0.0005705652,0.0073465854,0.00019276637],"about_ca_topic_score_codex":0.0016308428,"about_ca_topic_score_gemma":0.000940765,"teacher_disagreement_score":0.0027013319,"about_ca_system_score_codex":0.00067184906,"about_ca_system_score_gemma":0.0012144356,"threshold_uncertainty_score":0.011957467},"labels":[],"label_agreement":null},{"id":"W4387472477","doi":"10.1007/s13318-023-00857-1","title":"The Effects of 16-HETE Enantiomers on Hypertrophic Markers in Human Fetal Ventricular Cardiomyocytes, RL-14 Cells","year":2023,"lang":"en","type":"article","venue":"European Journal of Drug Metabolism and Pharmacokinetics","topic":"Eicosanoids and Hypertension Pharmacology","field":"Biochemistry, Genetics and Molecular Biology","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"Canadian Institutes of Health Research","keywords":"Biology; CYP1B1; Gene expression; Cytochrome P450; Endocrinology; Biochemistry; Gene; Enzyme","score_opus":0.006939423227047406,"score_gpt":0.2388003516835937,"score_spread":0.2318609284565463,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387472477","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9961725,0.0011219021,0.0005255442,0.00013599916,0.00009345677,0.00002274821,0.00065788266,0.000013636845,0.0012563721],"genre_scores_gemma":[0.9923104,0.0013798237,0.0012265537,0.00016623901,0.00005709863,0.000058769114,0.0011767035,0.000019350891,0.0036050659],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99962556,0.00010554866,0.000065602064,0.000062681436,0.00005165484,0.000088956185],"domain_scores_gemma":[0.99968946,0.00012475385,0.00003323663,0.000047317906,0.000043021813,0.000062234525],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00047674007,0.00027131414,0.00045751085,0.00015750053,0.00023731355,0.0003412721,0.00018872833,0.00040182602,0.0020227472],"category_scores_gemma":[0.0004052729,0.00019491476,0.000375257,0.00022371908,0.00034480586,0.0004236963,0.00020959413,0.00075878674,0.00041555756],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0055518653,0.00025815653,0.000758111,0.000088414905,0.000024916031,0.00024301198,0.00015396012,0.0001254115,0.98941004,0.00014229347,0.00016524695,0.0030785436],"study_design_scores_gemma":[0.00024150922,0.0041473634,0.012437795,0.000014137355,0.000076095705,0.00023189772,0.00037530888,0.0006170678,0.97928256,0.000080683894,0.0024754633,0.000020013922],"about_ca_topic_score_codex":0.0010214176,"about_ca_topic_score_gemma":0.0013247619,"teacher_disagreement_score":0.0020227472,"about_ca_system_score_codex":0.00016885066,"about_ca_system_score_gemma":0.00031385903,"threshold_uncertainty_score":0.0067667365},"labels":[],"label_agreement":null},{"id":"W4390048756","doi":"10.1007/s13318-023-00873-1","title":"Pharmacokinetics of Long-Acting Methylphenidate: Formulation Differences, Bioequivalence, Interchangeability","year":2023,"lang":"en","type":"review","venue":"European Journal of Drug Metabolism and Pharmacokinetics","topic":"Attention Deficit Hyperactivity Disorder","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Bioequivalence; Interchangeability; Pharmacokinetics; Medicine; Pharmacology; Methylphenidate; Computer science; Clinical psychology","score_opus":0.15939712643748805,"score_gpt":0.40506528951163384,"score_spread":0.2456681630741458,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4390048756","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00035552625,0.99908423,0.0001506049,0.00011678749,0.000050832332,0.0000043211844,0.000026661926,0.0000038133446,0.00020717419],"genre_scores_gemma":[0.003344982,0.99572253,0.00039559646,0.00014003488,0.00009559582,0.000008554957,0.000054170876,0.0000024021647,0.00023616073],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9994885,0.00012926152,0.000089804234,0.00009197624,0.00017724793,0.000023084827],"domain_scores_gemma":[0.9989679,0.0006581072,0.00020693704,0.000021278825,0.00012182963,0.000023878063],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002013673,0.00082498515,0.0028549114,0.0012530718,0.00013324393,0.0011701983,0.0010838752,0.0011971833,0.0023806046],"category_scores_gemma":[0.0021695276,0.00029888283,0.0014031944,0.0014644844,0.00038850566,0.0011224011,0.00044203218,0.0018141554,0.00052346074],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005941993,0.00010043914,0.00043838727,0.029056115,0.0010845814,0.00015640381,0.000036437163,0.0005929762,0.0017435298,0.0012191619,0.00615367,0.9588241],"study_design_scores_gemma":[0.001285279,0.0018038112,0.014426306,0.022705497,0.009416953,0.007149932,0.00023095091,0.0022823773,0.005127436,0.005090739,0.93032545,0.0001552342],"about_ca_topic_score_codex":0.0018177822,"about_ca_topic_score_gemma":0.002787477,"teacher_disagreement_score":0.0028549114,"about_ca_system_score_codex":0.0006159901,"about_ca_system_score_gemma":0.00089422835,"threshold_uncertainty_score":0.010649443},"labels":[],"label_agreement":null},{"id":"W4396653776","doi":"10.1007/s13318-024-00897-1","title":"Does Sample Size, Sampling Strategy, or Handling of Concentrations Below the Lower Limit of Quantification Matter When Externally Evaluating Population Pharmacokinetic Models?","year":2024,"lang":"en","type":"article","venue":"European Journal of Drug Metabolism and Pharmacokinetics","topic":"Antibiotics Pharmacokinetics and Efficacy","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Polytechnique Montréal","funders":"Fonds de Recherche du Québec - Santé; Canada Foundation for Innovation; Réseau Québécois de Recherche sur les Médicaments","keywords":"Sample size determination; NONMEM; Sampling (signal processing); Statistics; Population; Sample (material); Dosing; Pharmacokinetics; Medicine; Computer science; Econometrics; Mathematics; Pharmacology; Chromatography; Environmental health","score_opus":0.06829661251966955,"score_gpt":0.35187229925380314,"score_spread":0.2835756867341336,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4396653776","genre_codex":"methods","genre_gemma":"empirical","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.15207663,0.0069188313,0.8109554,0.014179243,0.002332168,0.0028370128,0.0013859989,0.0018160118,0.0074986615],"genre_scores_gemma":[0.5979911,0.0020726125,0.3843013,0.009178412,0.0010329082,0.0024053287,0.00088678446,0.00094894966,0.0011825806],"study_design_codex":"design_other","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.82652444,0.14318018,0.010876089,0.0049417745,0.013610048,0.0008674333],"domain_scores_gemma":[0.5355431,0.3987918,0.023066022,0.022616122,0.018884316,0.0010986899],"candidate_categories":["metaresearch"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.27742466,0.0012296161,0.0026197522,0.0011115781,0.0008560629,0.004053512,0.0024964877,0.00284341,0.0019238447],"category_scores_gemma":[0.53573304,0.00091353845,0.002104395,0.001278033,0.0034497185,0.0030735224,0.0016571735,0.0023438658,0.0008902721],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0071237376,0.0010661437,0.28441533,0.0059660547,0.010103869,0.0008996265,0.0036731565,0.026393382,0.033660628,0.017450672,0.022252401,0.5869949],"study_design_scores_gemma":[0.0030582517,0.013372253,0.37032637,0.008063946,0.01361026,0.0056572747,0.0022802514,0.24200697,0.1074422,0.10849136,0.12450452,0.0011863366],"about_ca_topic_score_codex":0.0023771727,"about_ca_topic_score_gemma":0.0040319436,"teacher_disagreement_score":0.7225753,"about_ca_system_score_codex":0.00094315095,"about_ca_system_score_gemma":0.002783378,"threshold_uncertainty_score":0.89106405},"labels":[],"label_agreement":null},{"id":"W4402580814","doi":"10.1007/s13318-024-00913-4","title":"Vancomycin in Pediatric Patients with Cystic Fibrosis: Dose Optimization Using Population Pharmacokinetic Approach","year":2024,"lang":"en","type":"article","venue":"European Journal of Drug Metabolism and Pharmacokinetics","topic":"Antimicrobial Resistance in Staphylococcus","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; Centre hospitalier de l'Université Laval; Centre Hospitalier Universitaire Sainte-Justine; Université de Montréal","funders":"Faculté de pharmacie, Université de Montréal; Fonds de Recherche du Québec - Santé","keywords":"Cystic fibrosis; Medicine; Vancomycin; Therapeutic drug monitoring; Pharmacokinetics; Antibiotics; Intensive care medicine; Population; Staphylococcus aureus; Drug; Population pharmacokinetics; Internal medicine; Pharmacology; Microbiology","score_opus":0.011781385841971428,"score_gpt":0.26011200746278657,"score_spread":0.24833062162081515,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402580814","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94581616,0.0054217903,0.045369096,0.00096602575,0.000029644656,0.00015588783,0.00019165024,0.00019537246,0.0018544511],"genre_scores_gemma":[0.9850863,0.0011949688,0.013209224,0.0001263565,0.000016257214,0.000056301677,0.00011146393,0.000024834892,0.00017432241],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9996357,0.0002009422,0.000029175346,0.000052953612,0.00005893194,0.000022251957],"domain_scores_gemma":[0.9995192,0.00028144976,0.00011048051,0.0000162022,0.00004243247,0.000030265253],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00053180003,0.00029458167,0.00092707225,0.00026515368,0.0001511533,0.00062980456,0.00022588795,0.00038949522,0.00040541106],"category_scores_gemma":[0.0025949688,0.00016391031,0.00037710567,0.00030549656,0.000113853464,0.00030201074,0.00024777892,0.0006664939,0.000074762334],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0069635087,0.0013829209,0.34363243,0.000414446,0.00097107544,0.0014291224,0.00043870637,0.17536563,0.014207318,0.0017121785,0.002605475,0.4508771],"study_design_scores_gemma":[0.0008445842,0.012802634,0.3406612,0.00026868502,0.00108256,0.006296492,0.00089041237,0.61036026,0.012258832,0.004933664,0.00951346,0.00008732738],"about_ca_topic_score_codex":0.0014172075,"about_ca_topic_score_gemma":0.001480582,"teacher_disagreement_score":0.0014172075,"about_ca_system_score_codex":0.0005049591,"about_ca_system_score_gemma":0.00085393456,"threshold_uncertainty_score":0.0036637187},"labels":[],"label_agreement":null},{"id":"W4412711389","doi":"10.1007/s13318-025-00960-5","title":"Population Pharmacokinetic Model Evaluation with a Small Real-World Dataset Versus a Large Virtual Dataset: Does Sample Size Affect Decision-Making?","year":2025,"lang":"en","type":"article","venue":"European Journal of Drug Metabolism and Pharmacokinetics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Polytechnique Montréal; McGill University Health Centre; Université de Montréal","funders":"Fonds de Recherche du Québec - Santé","keywords":"Affect (linguistics); Sample size determination; Sample (material); Pharmacokinetics; Population; Statistics; Medicine; Computer science; Psychology; Internal medicine; Mathematics; Chemistry; Chromatography; Environmental health","score_opus":0.0685641862903685,"score_gpt":0.42004607954738077,"score_spread":0.3514818932570123,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412711389","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8952467,0.002028314,0.088818416,0.0054036714,0.00047408155,0.00074861554,0.004059537,0.0007167312,0.002504027],"genre_scores_gemma":[0.97109467,0.00018282233,0.0247985,0.00077804446,0.000071364935,0.00029094337,0.0024272976,0.000051139617,0.00030523218],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9910636,0.007401195,0.0003178652,0.0007307309,0.00036119384,0.00012555726],"domain_scores_gemma":[0.889363,0.103297465,0.0016438228,0.0030810307,0.0019110477,0.00070364523],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.029256444,0.0007871137,0.0012503851,0.0004898268,0.00039453234,0.0014117298,0.001423504,0.0018442413,0.0019446162],"category_scores_gemma":[0.09091636,0.0004317095,0.0012976459,0.000343355,0.00073568575,0.0018074859,0.0008059864,0.0018638826,0.00030125558],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.015784696,0.0030877746,0.11761168,0.0010226246,0.0039952467,0.00069852284,0.0002772821,0.70869845,0.003298297,0.003675851,0.020517474,0.12133205],"study_design_scores_gemma":[0.0016459902,0.0016001681,0.013160509,0.00013697479,0.0006724042,0.00030229113,0.00015438384,0.9707173,0.0021387173,0.0069356035,0.0024727508,0.00006288963],"about_ca_topic_score_codex":0.002969056,"about_ca_topic_score_gemma":0.0029298423,"teacher_disagreement_score":0.029256444,"about_ca_system_score_codex":0.0006957216,"about_ca_system_score_gemma":0.0014745136,"threshold_uncertainty_score":0.15472472},"labels":[],"label_agreement":null}]}